These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7883087)

  • 1. Analytical strategies for the determination of protein modifications.
    Janis LJ; Davis GC
    Dev Biol Stand; 1994; 83():135-42. PubMed ID: 7883087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency and stability of recombinant fermentations.
    Wiebe ME; Builder SE
    Dev Biol Stand; 1994; 83():45-54. PubMed ID: 7883099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of biotechnological production processes.
    Werner RG; Langlouis-Gau H; Walz F; Allgaier H; Hoffmann H
    Arzneimittelforschung; 1988 Jun; 38(6):855-62. PubMed ID: 3052464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical considerations in the development of protein purification processes.
    Anicetti V; Hancock WS
    Bioprocess Technol; 1994; 18():11-36. PubMed ID: 7764169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biosensors to characterize recombinant proteins.
    Van Regenmortel MH
    Dev Biol Stand; 1994; 83():143-51. PubMed ID: 7883088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography.
    Johnson C; Royal M; Moreadith R; Bedu-Addo F; Advant S; Wan M; Conn G
    Biomed Chromatogr; 2003 Jul; 17(5):335-44. PubMed ID: 12884399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and phenotypic markers and their relationship to product quality and consistency.
    Adamson SR; Charlebois TS
    Dev Biol Stand; 1994; 83():31-44. PubMed ID: 7883098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of assay validation in specification development.
    Baffi RA
    Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrared spectroscopy for biopharmaceutical protein analysis.
    Gross PC; Zeppezauer M
    J Pharm Biomed Anal; 2010 Sep; 53(1):29-36. PubMed ID: 20381986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein purification: aspects of processes for pharmaceutical products.
    Berthold W; Walter J
    Biologicals; 1994 Jun; 22(2):135-50. PubMed ID: 7917230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analytical biotechnology of recombinant peptides and proteins. I. Analysis of the purity, composition and structure of human, porcine and bovine insulins].
    Sergeev NV; Nazimov IV; Gavrikov VG; Miroshnikov AI
    Bioorg Khim; 2000 Jan; 26(1):25-30. PubMed ID: 10806549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene stability in mammalian cells and protein consistency.
    Berthold W
    Dev Biol Stand; 1994; 83():67-79. PubMed ID: 7883100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic stability and recombinant product consistency.
    Burstyn D; Copmann T; Dinowitz M; Garnick R; Losikoff A; Lubiniecki A; Wiebe M
    Biologicals; 1993 Jun; 21(2):147-9. PubMed ID: 8297595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry in the standardisation of recombinant products.
    Geisow MJ
    Dev Biol Stand; 1994; 83():129-33. PubMed ID: 7883085
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of protein purity.
    Rhodes DG; Laue TM
    Methods Enzymol; 2009; 463():677-89. PubMed ID: 19892198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bioassays in the assessment of recombinant proteins.
    Jeffcoate SL
    Dev Biol Stand; 1994; 83():159-64. PubMed ID: 7883090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.